PANDION THERAPEUTICS, INC. Operating Income
PANDION THERAPEUTICS, INC. reported Operating Income of -$37.93 million for the 12-month period ending 2020-12-31, per its 10-K filed 2021-03-12.
Discontinued › Income Statement
us-gaap:OperatingIncomeLoss · last filed 2021-03-12
- PANDION THERAPEUTICS, INC. operating income (loss) for the quarter ending 2020-12-31 was -$11.23M.
- PANDION THERAPEUTICS, INC. operating income (loss) for the quarter ending 2020-09-30 was -$10.99M.
- PANDION THERAPEUTICS, INC. operating income (loss) for the quarter ending 2020-06-30 was -$9.20M.
- PANDION THERAPEUTICS, INC. operating income (loss) for the quarter ending 2020-03-31 was -$6.51M.
- PANDION THERAPEUTICS, INC. operating income (loss) for fiscal 2020 was -$37.93M.
- PANDION THERAPEUTICS, INC. operating income (loss) for fiscal 2019 was -$22.22M.
| Period end | Operating Income (Loss) 3 month | Operating Income (Loss) 6 month | Operating Income (Loss) 9 month | Operating Income (Loss) 12 month |
|---|---|---|---|---|
| 2020-12-31 | -$11.23M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-12 | -$22.22M derived: sum of 2 quarters · filed 2021-03-12 | -$31.42M derived: sum of 3 quarters · filed 2021-03-12 | -$37.93M 10-K · filed 2021-03-12 |
| 2020-09-30 | -$10.99M 10-Q · filed 2020-11-16 | -$20.19M derived: sum of 2 quarters · filed 2020-11-16 | -$26.70M 10-Q · filed 2020-11-16 | -$31.38M derived: sum of 4 quarters · filed 2021-03-12 |
| 2020-06-30 | -$9.20M 10-Q · filed 2020-08-31 | -$15.71M 10-Q · filed 2020-08-31 | -$20.39M derived: sum of 3 quarters · filed 2021-03-12 | -$26.30M derived: sum of 4 quarters · filed 2021-03-12 |
| 2020-03-31 | -$6.51M derived: 10-K 12 month − 3 quarters · filed 2021-03-12 | -$11.19M derived: sum of 2 quarters · filed 2021-03-12 | -$17.09M derived: sum of 3 quarters · filed 2021-03-12 | -$22.87M derived: sum of 4 quarters · filed 2021-03-12 |
| 2019-12-31 | -$4.68M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-12 | -$10.59M derived: sum of 2 quarters · filed 2021-03-12 | -$16.36M derived: sum of 3 quarters · filed 2021-03-12 | -$22.22M 10-K · filed 2021-03-12 |
| 2019-09-30 | -$5.91M 10-Q · filed 2020-11-16 | -$11.68M derived: sum of 2 quarters · filed 2020-11-16 | -$17.54M 10-Q · filed 2020-11-16 | |
| 2019-06-30 | -$5.77M 10-Q · filed 2020-08-31 | -$11.63M 10-Q · filed 2020-08-31 |